These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33769169)

  • 1. Management of pregnancies complicated by placenta accreta spectrum utilizing a multidisciplinary care team in a rural state.
    Sandlin AT; Magann EF; Whittington JR; Schneider AM; Ramseyer AM; Hughes DS; Ounpraseuth ST
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5964-5969. PubMed ID: 33769169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.
    Zuckerwise LC; Craig AM; Newton JM; Zhao S; Bennett KA; Crispens MA
    Am J Obstet Gynecol; 2020 Feb; 222(2):179.e1-179.e9. PubMed ID: 31469990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional multidisciplinary team approach to the management of placenta accreta spectrum disorder.
    Yao R; Nguyen HY; Hong L; Karagoyzyan D; Burruss S; Brar H; Staton M; Martin C; Balli K; Ioffe Y
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2190840. PubMed ID: 36927241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
    Melber DJ; Berman ZT; Jacobs MB; Picel AC; Conturie CL; Zhang-Rutledge K; Binder PS; Eskander RN; Roberts AC; McHale MT; Ramos GA; Ballas J; Kelly TF
    Am J Obstet Gynecol; 2021 Oct; 225(4):442.e1-442.e10. PubMed ID: 34245679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5-year experience on perinatal outcome of placenta accreta spectrum disorder managed by cesarean hysterectomy in southern Iranian women.
    Kasraeian M; Hashemi A; Hessami K; Alamdarloo SM; Vahdani R; Vafaei H; Najib FS; Shiravani Z; Razavi B; Homayoon N; Nayebi M; Bazrafshan K; Jahromi MA
    BMC Womens Health; 2021 Jun; 21(1):243. PubMed ID: 34130685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta accreta spectrum: We can do better.
    Silveira C; Kirby A; Melov SJ; Nayyar R
    Aust N Z J Obstet Gynaecol; 2022 Jun; 62(3):376-382. PubMed ID: 34984671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa.
    Mulla BM; Weatherford R; Redhunt AM; Modest AM; Hacker MR; Hecht JL; Spiel MH; Shainker SA
    Arch Gynecol Obstet; 2019 Dec; 300(6):1601-1606. PubMed ID: 31691015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Gynecol Oncol; 2022 Sep; 166(3):460-464. PubMed ID: 35781164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and neonatal outcomes following a proactive peripartum multidisciplinary management protocol for placenta creta spectrum as compared to the urgent delivery.
    Stanleigh J; Michaeli J; Armon S; Khatib F; Zuckerman B; Shaya M; Ioscovitch A; Shenfeld O; Greenblat D; Farkash R; Tevet A; Samueloff A; Grisaru Granovsky S
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():139-144. PubMed ID: 31039488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic endovascular internal iliac balloon placement during cesarean hysterectomy for placenta accreta spectrum.
    Overton E; Booker WA; Mourad M; Moroz L; Nhan Chang CL; Breslin N; Syeda S; Laifer-Narin S; Cimic A; Chung DE; Weiner DM; Smiley R; Sheikh M; Mobley DG; Wright JD; Gockley A; Melamed A; St Clair C; Hou J; D'Alton M; Khoury Collado F
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100657. PubMed ID: 35597402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time.
    Shamshirsaz AA; Fox KA; Erfani H; Clark SL; Salmanian B; Baker BW; Coburn M; Shamshirsaz AA; Bateni ZH; Espinoza J; Nassr AA; Popek EJ; Hui SK; Teruya J; Tung CS; Jones JA; Rac M; Dildy GA; Belfort MA
    Am J Obstet Gynecol; 2017 Jun; 216(6):612.e1-612.e5. PubMed ID: 28213059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: A ten-year experience.
    Yasin N; Slade L; Atkinson E; Kennedy-Andrews S; Scroggs S; Grivell R
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):550-554. PubMed ID: 30565213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and fetal outcomes in placenta accreta after institution of team-managed care.
    Al-Khan A; Gupta V; Illsley NP; Mannion C; Koenig C; Bogomol A; Alvarez M; Zamudio S
    Reprod Sci; 2014 Jun; 21(6):761-71. PubMed ID: 24336676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved management of placenta accreta spectrum disorders: experience from a single institution.
    Sylvester-Armstrong K; Reeder C; Patrick K; Genc MR
    J Perinat Med; 2022 Mar; 50(3):286-293. PubMed ID: 34905811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss.
    Seoud MA; Nasr R; Berjawi GA; Zaatari GS; Seoud TM; Shatila AS; Mirza FG
    J Neonatal Perinatal Med; 2017; 10(1):9-15. PubMed ID: 28304318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS).
    Munoz JL; Pfeiffer AF; Curbelo J; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8640-8644. PubMed ID: 34657560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the multidisciplinary team approaches to placenta accreta spectrum across five institutions within the University of California fetal Consortium (UCfC).
    Fratto VM; Conturie CL; Ballas J; Pettit KE; Stephenson ML; Truong YN; Henry D; Afshar Y; Murphy A; Kim L; Field N; Wing DA; Norton ME; Ramos GA;
    J Matern Fetal Neonatal Med; 2021 Sep; 34(18):2971-2976. PubMed ID: 31645153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical advances in the management of placenta accreta spectrum: establishing new expectations for operative blood loss.
    Cojocaru L; Lankford A; Galey J; Bharadwaj S; Kodali BS; Kennedy K; Goetzinger K; Turan OM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(23):4496-4505. PubMed ID: 33272057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of surgical management of placenta accreta spectrum in a tertiary center in Sri Lanka: baseline study for quality improvement project: problems and solutions.
    Wijesinghe V; Rishard M; Srisanjeevan S
    BMC Pregnancy Childbirth; 2022 Jun; 22(1):509. PubMed ID: 35739493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.